Diabetes Care, Vol 9, Issue 5 443-452, Copyright © 1986 by American Diabetes Association

ARTICLES

Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study

AS Krolewski, JH Warram, LI Rand, AR Christlieb, EJ Busick and CR Kahn

The development of proliferative diabetic retinopathy was studied in three cohorts consisting of 292 patients with recent juvenile-onset, type I (insulin-dependent) diabetes who were followed 20-40 yr beginning in 1939, 1949, and 1959. The risk of this severe eye complication was almost nonexistent during the first 10 yr of diabetes, rose abruptly to its maximum level (approximately 30/100 person-years), and remained at that level for the next 25 yr. This pattern did not vary with sex, age at onset of diabetes, or level of glycemic control during the first 5 yr of diabetes. However, the risk of proliferative retinopathy was strongly related to the level of glycemic control during the several years preceding onset of this complication. This was a dose-dependent relationship, with patients in the highest quartile of the distribution of the index of frequency of hyperglycemia having a 10-fold higher risk than individuals in the lowest quartile. A virtually identical pattern was observed in patients who developed diabetes in 1959 as was observed in those who developed diabetes in 1949 or 1939. In contrast, diabetic nephropathy as evidenced by persistent proteinuria showed a lower incidence in the 1959 than in the 1939 cohort. In conclusion, these incidence data do not support the notion that the risk of proliferative retinopathy is mainly a function of duration of diabetes. Instead, the pattern of occurrence of this severe eye complication in type I diabetes suggests that the process leading to the development of proliferative retinopathy consists of two or more stages and that progression through each stage may be governed by different factors.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. E. Carroll, R. T. Ackermann, E. J. Brizendine, C. Shen, and D. G. Marrero Does Age at Diabetes Diagnosis Influence Long-Term Physical and Behavioral Outcomes? Diabetes Care, November 1, 2007; 30(11): 2859 - 2860. [Full Text] [PDF]

				B. R. Conway, D. A. Savage, and A. Peter Maxwell Identifying genes for diabetic nephropathy--current difficulties and future directions Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3012 - 3017. [Full Text] [PDF]

				M. S. Roy and M. Affouf Six-year progression of retinopathy and associated risk factors in african american patients with type 1 diabetes mellitus: the new jersey 725. Arch Ophthalmol, September 1, 2006; 124(9): 1297 - 1306. [Abstract] [Full Text] [PDF]

				G. Pambianco, T. Costacou, D. Ellis, D. J. Becker, R. Klein, and T. J. Orchard The 30-year natural history of type 1 diabetes complications: the pittsburgh epidemiology of diabetes complications study experience. Diabetes, May 1, 2006; 55(5): 1463 - 1469. [Abstract] [Full Text] [PDF]

				B. R. Conway, R. Martin, A.-J. McKnight, D. A. Savage, H. R. Brady, and A. P. Maxwell Role of {alpha}-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2019 - 2024. [Abstract] [Full Text] [PDF]

				A. N. Friedman, C. Catena, M. Novello, L. A. Sechi, D. Hohenadel, H. Bode, F. J. van der Woude, G. Zerbini, B. A. Perkins, J. H. Warram, et al. Regression of Microalbuminuria in Type 1 Diabetes N. Engl. J. Med., August 28, 2003; 349(9): 906 - 908. [Full Text] [PDF]

				P. Hovind, L. Tarnow, K. Rossing, P. Rossing, S. Eising, N. Larsen, C. Binder, and H.-H. Parving Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes Diabetes Care, April 1, 2003; 26(4): 1258 - 1264. [Abstract] [Full Text] [PDF]

				J. J. Rogus, J. H. Warram, and A. S. Krolewski Genetic Studies of Late Diabetic Complications: The Overlooked Importance of Diabetes Duration Before Complication Onset Diabetes, June 1, 2002; 51(6): 1655 - 1662. [Abstract] [Full Text] [PDF]

				M. S. Roy Diabetic Retinopathy in African Americans With Type 1 Diabetes: The New Jersey 725: I. Methodology, Population, Frequency of Retinopathy, and Visual Impairment Arch Ophthalmol, January 1, 2000; 118(1): 97 - 104. [Abstract] [Full Text] [PDF]

				M. S. Roy Diabetic Retinopathy in African Americans With Type 1 Diabetes: The New Jersey 725: II. Risk Factors Arch Ophthalmol, January 1, 2000; 118(1): 105 - 119. [Abstract] [Full Text] [PDF]

				C A Jones, G P Leese, S Kerr, K Bestwick, D I Isherwood, J P Vora, D A Hughes, and C Smith Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus Arch. Dis. Child., June 1, 1998; 78(6): 518 - 523. [Abstract] [Full Text]

				A. C. Rydall, G. M. Rodin, M. P. Olmsted, R. G. Devenyi, and D. Daneman Disordered Eating Behavior and Microvascular Complications in Young Women with Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., June 26, 1997; 336(26): 1849 - 1854. [Abstract] [Full Text] [PDF]

				R. Klein, B. E. K. Klein, and S. E. Moss Relation of Glycemic Control to Diabetic Microvascular Complications in Diabetes Mellitus Ann Intern Med, January 1, 1996; 124(1_Part_2): 90 - 96. [Abstract] [Full Text]

				D. M. Nathan Long-Term Complications of Diabetes Mellitus N. Engl. J. Med., June 10, 1993; 328(23): 1676 - 1685. [Full Text]

				S. E. Pollock, J. A. Verran, K. Hoare, and H. C. Solomons Adaptive Responses to Diabetes Mellitus West J Nurs Res, June 1, 1989; 11(3): 265 - 280. [PDF]

				M. Bernbaum, S. G. Albert, S. R. Brusca, A. Drimmer, P. N. Duckro, J. D. Cohen, M. C. Trindade, and A. B. Silverberg A Model Clinical Program for Patients With Diabetes and Vision Impairment The Diabetes Educator, January 1, 1989; 15(4): 325 - 330. [PDF]